Brief: Xvivo Q3 EBIT SEK 28 Million
BRIEF-Xvivo Q3 EBIT SEK 28 Million Oct 22 (Reuters) - Xvivo Q3 net income SEK 44.6 million.
- Q3 EPS SEK 1.42
- Q3 sales SEK 252.6 million vs. IBES estimate SEK 234.4 million
Recent news on Xvivo Perfusion AB
See all newsSweden's XVIVO Q3 revenue beat expectations on thoracic sales
Brief: Xvivo Q3 EBIT SEK 28 Million
Brief: Xvivo Receives CE Certificates For Heart Preservation Technology
Brief: XVIVO Gets FDA Approval For Additional Patient Enrollment
Sweden's XVIVO Q2 sales beat estimates, helped by thoracic segment strength